Inge de Clercq
Head of Clinical Trials Leaders Phase 1 GALAPAGOS, Belgium
Educational background
- Master in Industrial Sciences Biochemistry (1990)
- DMAIC Six Sigma black belt (2003)
Professional record
- Galapagos NV – Director, Head of Clinical Study Leaders Phase 1 (since Feb 2017)
- Tactical management and leadership to the Clinical Operations Phase 1 subdepartment
- AMGEN NV – Regional Clinical Trial Manager (2010 – 2017)
- Regional study management of early phase I studies, phase II and III studies in the domain of osteoporosis, inflammation, cardiology and neurosciences
- TIBOTEC-VIRCO (Outsourced by Valesta) – Global Trial Manager (2006 – 2010)
- Global study management and oversight of phase I, phase II and phase III trial in the domain of infectious diseases
- SGS NV, Clinical Pharmacology Unit (1991 – 2006)
- Different roles from the site’s first Clinical Research Coordinator to Linemanager Project Coordination (responsible for recruitment staff, clinical trial assistants and clinical research coordinators)
- As Six Sigma Black Belt, acting as Manager Continuous Improvement for the SGSLife Science QC labs in Europe (2003 – 2004)
CONTACT
For more information about your participation, please contact us at info@clinicaltrialsymposium.com
For additional information regarding partnership, sponsors & exhibitors and media, please contact our
marketing and communication department at anca.bejenaru@avantyo.com